Curated News
By: NewsRamp Editorial Staff
October 10, 2024

AGC Biologics Completes Milestone at New Manufacturing Building in Copenhagen

Reddit Discuss on RedditDiscuss on LinkedIn LinkedInDiscuss on Telegram TelegramView History of this news story on GitHub Github
Source News Release

TLDR

  • AGC Biologics completed a new manufacturing building in Copenhagen, doubling mammalian manufacturing capacity, giving them a competitive edge in the biopharmaceutical CDMO industry.
  • The new facility at AGC Biologics Copenhagen uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors and dedicated quality control laboratory spaces.
  • AGC Biologics' new manufacturing building will allow them to produce more treatments than ever before, contributing to the development of life-saving therapies and making the world a better place.
  • AGC Biologics' successful completion of the final milestone at its new manufacturing building in Copenhagen marks a significant advancement in biopharmaceutical manufacturing technology.

Impact - Why it Matters

This news matters because it demonstrates AGC Biologics' commitment to expanding its manufacturing capabilities, providing more treatment options, and serving as a top location for developer partners seeking CDMO services in Europe. The successful completion of the milestone also reflects the company's dedication to continuous innovation and solving clients' most complex challenges.

Summary

AGC Biologics has successfully completed the final milestone at its new manufacturing building in Copenhagen, receiving authorization and a license from the Danish Medicines Agency to begin production. The new facility has doubled the capacity for mammalian manufacturing and started production on a phase II/III clinical project using the latest mammalian systems and single-use technology. AGC Biologics Copenhagen has an extensive operational track record and expertise spanning early-stage development through clinical and commercial manufacturing.

Source Statement

This curated news summary relied on this press release disributed by News Direct. Read the source press release here, AGC Biologics Completes Milestone at New Manufacturing Building in Copenhagen

blockchain registration record for the source press release.